
Jury orders Tesla to pay more than $240 million in Autopilot crash case
The federal jury held that Tesla bore significant responsibility because its technology failed and that not all the blame can be put on a reckless driver, even one who admitted he was distracted by his cellphone before hitting a young couple out gazing at the stars. The decision comes as Musk seeks to convince Americans his cars are safe enough to drive on their own as he plans to roll out a driverless taxi service in several cities in the coming months.
The decision ends a four-year long case remarkable not just in its outcome but that it even made it to trial. Many similar cases against Tesla have been dismissed and, when that didn't happen, settled by the company to avoid the spotlight of a trial.
'This will open the floodgates,' said Miguel Custodio, a car crash lawyer not involved in the Tesla case. 'It will embolden a lot of people to come to court.'
The case also included startling charges by lawyers for the family of the deceased, 22-year-old, Naibel Benavides Leon, and for her injured boyfriend, Dillon Angulo. They claimed Tesla either hid or lost key evidence, including data and video recorded seconds before the accident. Tesla said it made a mistake after being shown the evidence and honestly hadn't thought it was there.
'We finally learned what happened that night, that the car was actually defective,' said Benavides' sister, Neima Benavides. 'Justice was achieved.'
Tesla has previously faced criticism that it is slow to cough up crucial data by relatives of other victims in Tesla crashes, accusations that the car company has denied. In this case, the plaintiffs showed Tesla had the evidence all along, despite its repeated denials, by hiring a forensic data expert who dug it up.
'Today's verdict is wrong,' Tesla said in a statement, 'and only works to set back automotive safety and jeopardize Tesla's and the entire industry's efforts to develop and implement lifesaving technology,' They said the plaintiffs concocted a story 'blaming the car when the driver – from day one – admitted and accepted responsibility.'
In addition to a punitive award of $200 million, the jury said Tesla must also pay $43 million of a total $129 million in compensatory damages for the crash, bringing the total borne by the company to $243 million.
'It's a big number that will send shock waves to others in the industry,' said financial analyst Dan Ives of Wedbush Securities. 'It's not a good day for Tesla.'
Tesla said it will appeal.
Even if that fails, the company says it will end up paying far less than what the jury decided because of a pre-trial agreement that limits punitive damages to three times Tesla's compensatory damages. Translation: $172 million, not $243 million. But the plaintiff says their deal was based on a multiple of all compensatory damages, not just Tesla's, and the figure the jury awarded is the one the company will have to pay.
It's not clear how much of a hit to Tesla's reputation for safety the verdict in the Miami case will make. Tesla has vastly improved its technology since the crash on a dark, rural road in Key Largo, Florida, in 2019.
But the issue of trust generally in the company came up several times in the case, including in closing arguments Thursday. The plaintiffs' lead lawyer, Brett Schreiber, said Tesla's decision to even use the term Autopilot showed it was willing to mislead people and take big risks with their lives because the system only helps drivers with lane changes, slowing a car and other tasks, falling far short of driving the car itself.
Schreiber said other automakers use terms like 'driver assist' and 'copilot' to make sure drivers don't rely too much on the technology.
'Words matter,' Schreiber said. 'And if someone is playing fast and lose with words, they're playing fast and lose with information and facts.'
Schreiber acknowledged that the driver, George McGee, was negligent when he blew through flashing lights, a stop sign and a T-intersection at 62 miles an hour before slamming into a Chevrolet Tahoe that the couple had parked to get a look at the stars.
The Tahoe spun around so hard it was able to launch Benavides 75 feet through the air into nearby woods where her body was later found. It also left Angulo, who walked into the courtroom Friday with a limp and cushion to sit on, with broken bones and a traumatic brain injury.
But Schreiber said Tesla was at fault nonetheless. He said Tesla allowed drivers to act recklessly by not disengaging the Autopilot as soon as they begin to show signs of distraction and by allowing them to use the system on smaller roads that it was not designed for, like the one McGee was driving on.
'I trusted the technology too much,' said McGee at one point in his testimony. 'I believed that if the car saw something in front of it, it would provide a warning and apply the brakes.'
The lead defense lawyer in the Miami case, Joel Smith, countered that Tesla warns drivers that they must keep their eyes on the road and hands on the wheel yet McGee chose not to do that while he looked for a dropped cellphone, adding to the danger by speeding. Noting that McGee had gone through the same intersection 30 or 40 times previously and hadn't crashed during any of those trips, Smith said that isolated the cause to one thing alone: 'The cause is that he dropped his cellphone.'
The auto industry has been watching the case closely because a finding of Tesla liability despite a driver's admission of reckless behavior would pose significant legal risks for every company as they develop cars that increasingly drive themselves.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
5 hours ago
- Economic Times
Novo Nordisk CEO warns of layoffs as Wegovy challenge heats up
Synopsis Novo Nordisk warned of ongoing competition from copycat versions of its obesity drug Wegovy and signaled possible layoffs due to slowing sales growth, especially in the U.S. The Danish drugmaker, which lost $95 billion in market value after cutting full-year forecasts, said over one million Americans still use compounded GLP-1 drugs despite a U.S. ban. Reuters Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could face layoffs as it battles rising pressure from main U.S. rival Eli Lilly, the Danish drugmaker warned on Wednesday. Novo, which became Europe's most valuable company worth $650 billion last year on booming sales of Wegovy, is facing a pivotal moment as the medicine loses market share and sees sales growth slow, especially in the United States. It has warned of far slower growth this year - in part due to compounders who have been allowed to make copycat medicines based on the same ingredients as Wegovy due to shortages. Novo cut its full-year sales and profit forecasts last week, wiping $95 billion off its market value since. The shares were down 3.4% at 1350 GMT. The slide is a huge and abrupt turnaround for the firm that has been one of the world's hottest investment stories, which led to a rapid expansion of manufacturing and sales capacity. Now the firm is eyeing potential cost-cutting measures. "We probably won't be able to avoid layoffs," outgoing CEO Lars Fruergaard Jorgensen told Danish broadcaster DR. "When you have to adjust a company, there are some areas where you have to have fewer people, some (areas) where you have to be smaller." He added, though, that any decision on layoffs would be in the hands of the incoming CEO, company veteran Maziar Mike Doustdar, who takes over on Thursday. On a media call, Jorgensen said the market for copycat versions of Wegovy's class of drugs - known as GLP-1 receptor agonists - was of "equal size to our business" and compounded versions of Wegovy were sold at a "much lower price point". In May, the company said it expected many of the roughly one million U.S. patients using compounded GLP-1 drugs to switch to branded treatments after a U.S. Food and Drug Administration ban on compounded copies of Wegovy took effect on May 22, and it expected compounding to wind down in the third quarter. However, finance chief Karsten Munk Knudsen said on Wednesday that more than one million U.S. patients were still using compounded GLP-1s and that Novo's lowered outlook has "not assumed a reduction in compounding" this year. "The obesity market is volatile," Knudsen told analysts when asked under what circumstances the company could see negative growth in the last six months of the year. The low end of Novo's new full-year guidance range would be for "unforeseen events", such as stronger pricing pressure in the U.S. than forecast, he said. The lower end of the range would imply sales around 150 billion Danish crowns ($23 billion) in the second half of 2025, compared with 157 billion in the same period last year. ENCOURAGING PRESCRIPTION DATA Knudsen reiterated that the company was pursuing multiple strategies, including lawsuits against compounding pharmacies, to halt unlawful mass compounding. Jorgensen said the company was encouraged by the latest U.S. prescription data for Wegovy. While the drug was overtaken earlier this year by rival Lilly's Zepbound in terms of U.S. prescriptions, that lead has narrowed in the past month. Second-quarter sales of Wegovy rose by 36% in the U.S. and more than quadrupled in markets outside the U.S. compared to a year ago, Novo said. While Wegovy's U.S. pricing held steady in the quarter, the company expected deeper erosion in the key U.S. market in the second half, due to a greater portion of sales expected from the direct-to-consumer or cash-pay channel, as well as higher rebates and discounts to insurers, Knudsen said. He said Novo was expanding its U.S. direct-to-consumer platform, NovoCare, launched in March, and may need to pursue similar "cash sales" directly to patients, outside of insurance channels, in some markets outside the United States. COST CUTS The company reiterated its full-year earnings expectations on Wednesday after last week's profit warning. Jorgensen said Novo was acting to "ensure efficiencies in our cost base" as the company announced it would terminate eight R&D projects. "There seems to be a larger R&D clean-out than usual, but we do not know if this reflects a strategic re-assessment or just a coincidence," Jefferies analysts said in a note. Investors have questioned whether Novo can stay competitive in the booming weight-loss drug market. Several equity analysts have cut their price targets and recommendation on the stock since last week. Shares in Novo plunged 30% last week - their worst weekly performance in over two decades. Sales rose 18% in the second quarter to 76.86 billion Danish crowns, below analysts' initial expectations.


India Today
5 hours ago
- India Today
Trump administration sanctions Mexican rapper over allegations of cartel ties
The Trump administration announced on Wednesday that it was sanctioning Mexican musician Ricardo Hernndez, known as 'El Makabelico,' over allegations that the artist was laundering money for a drug move comes after the administration stripped the visas of some of Mexico's most famous musicians, targeting those whose genres often explore themes related to US Treasury Department has taken action against the musician who is also identified as a "narco-rapper," for his alleged ties to the Cartel del Noreste (CDN), which evolved from the Zetas Cartel. The musician, named Hernndez, is accused of laundering money for the criminal organisation through his concerts and events. The CDN is among several Latin American crime groups designated as foreign terrorist organisations by the Trump According to the Treasury Department's allegations, Hernndez has been sanctioned because he is believed to be acting for or on behalf of the CDN. The department claims that half of his streaming royalties are funnelled directly to the cartel. The sanctions also extend to leaders of the has however, not been an official response from the rapper about the sanctions imposed on FROM THE TREASURY DEPARTMENT'CDN depends on these alternative revenue streams and money laundering methods to boost their criminal enterprise, diversifying their income beyond criminal activity like drug trafficking, human smuggling, and extortion," wrote the Treasury Department in a news release."The Treasury Department will continue to be relentless in its effort to put America First by targeting terrorist drug cartels. These cartels poison Americans with fentanyl and conduct human smuggling operations along our southwest border," said U.S. Treasury Secretary Scott US Treasury Department also took it to their social media handle on X to announce the sanctions on the rapper along with three high-ranking members of the Treasury's Office of Foreign Assets Control sanctioned three high-ranking members of the Mexico-based terrorist organization Cartel del Noreste (CDN), along with narco-rapper El narco-rapper's concerts and events are used to launder money on behalf of CDN,— Treasury Department (@USTreasury) August 6, 2025THE SANCTIONThe sanctions imposed will result in blocking the rapper's properties in US and freeze financial transactions with any businesses owned by those sanctioned, and threaten secondary sanctions against foreign financial institutions that do business with recent years, emerging artists like Peso Pluma have propelled Mexican music genres onto the global stage by blending traditional sounds with trap and other contemporary influences, rivalling international stars such as Taylor Swift and Bad Bunny on streaming genres — particularly 'narco-corridos' — have sparked much controversy, as many performers reference drug cartels and the broader 'narco culture.' While some tracks glorify criminal figures, others reflect the difficult realities faced by youth in cartel-dominated regions, drawing parallels to themes often explored in American style of music has been at the heart of ongoing debates over the boundaries between free artistic expression and censorship, with several Mexican states previously prohibiting live performances of certain ADMINISTRATION'S PREVIOUS STEPSadvertisementIn recent months, the Trump administration has taken action by revoking visas for several artists associated with the genre. In May, the well-known northern Mexican group Grupo Firme, which has worked to move away from cartel-related content, announced the cancellation of a planned California concert due to visa April, the administration said it was revoking the visas of the band Alegres de Barranco after they flashed the face of a cartel boss behind them at a concert, prompting a controversy and even criminal investigations in Mexico.- EndsWith inputs from agencies


India Today
5 hours ago
- India Today
Federal court upholds SEC ‘gag rule' in 3-0 ruling over free speech objections
A federal appeals court on Wednesday upheld the US Securities and Exchange Commission's so-called "gag rule," rejecting a claim it illegally silences defendants who want to criticise the regulator after settling civil enforcement a 3-0 decision, the 9th US Circuit Court of Appeals said the rule was not unconstitutional on its face, but could violate the First Amendment depending on how it is rule, reflecting SEC policy dating to 1972, often requires settling defendants to say at least that they neither admit nor deny the regulator's allegations. Twelve petitioners had been appealing the SEC's decision in January 2024 not to amend the rule, including eight people whose SEC settlements triggered petitioner, former Xerox chief financial officer Barry Romeril, took a similar case to the US Supreme Court in 2022 in an appeal backed by billionaire and longtime SEC critic Elon Musk, but that court refused to consider Wednesday's decision, Circuit Judge Daniel Bress said that while some defendants find the rule coercive, they remained free not to settle, and instead to speak out against the also said the SEC had an interest in deciding how to try its own cases, including by giving defendants different options, knowing that scrapping the rule could lead to fewer settlements."Provided that any limitation on speech remains within proper bounds, and given the background ability to waive First Amendment rights at least to some extent, the SEC has an interest in giving defendants the option to agree to a speech restriction as part of a broader settlement agreement," Bress said challenges to applying the rule could still be brought before the SEC brings enforcement cases, while judges consider settlements, or when the SEC reopens settled cases because of alleged petitioners included the New Civil Liberties Alliance, which challenges perceived administrative law senior litigation counsel Peggy Little said in a statement the nonprofit was disappointed. "Past practice does not excuse unconstitutional government action," she SEC had no immediate Commissioner Hester Peirce dissented from the regulator's decision not to amend the found "scant factual basis" for the rule, and said prohibiting denials of wrongdoing "prevents the American public from ever hearing criticisms that might otherwise be lodged against the government, let alone assessing their credibility."- Ends